David Dove
Chairman at Intera Oncology, Inc.
Profile
David Dove currently works at Intera Oncology, Inc., as Chairman and Atacama Therapeutics, Inc., as Director.
Dr. Dove also formerly worked at Shire Regenerative Medicine, Inc., as President & Chief Executive Officer, Aeris Therapeutics LLC, as President & Chief Executive Officer, Immunotherapy Corp., as Chief Executive Officer, and TEI Biosciences, Inc., as President & Chief Executive Officer.
Dr. Dove received his undergraduate degree from Middlebury College, doctorate degree from New York University, and Masters Business Admin degree from the University of California, Berkeley.
David Dove active positions
| Companies | Position | Start |
|---|---|---|
Intera Oncology, Inc.
 Intera Oncology, Inc. Medical DistributorsDistribution Services Intera Oncology, Inc. provides healthcare services. The company is headquartered in Wellesley, MA. | Chairman | - |
Atacama Therapeutics, Inc.
 Atacama Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Atacama Therapeutics, Inc. is a company that focuses on developing treatments for acne vulgaris. The company is based in Wellesley, MA. The company has a pipeline product called AT-5214. The company was founded by Jefferson E. Davis, Jonathan Reis, Joseph Baron. Joseph Baron has been the CEO since incorporation. | Director/Board Member | - |
Former positions of David Dove
| Companies | Position | End |
|---|---|---|
Aeris Therapeutics LLC
 Aeris Therapeutics LLC Medical SpecialtiesHealth Technology Aeris Therapeutics LLC develops therapies for patients with emphysema and other lung diseases. Its product AeriSeal System is designed to reduce lung volume in order to improve lung function and quality of life in patients with advanced emphysema. The company was founded in 2001 and it is headquartered in Woburn, MA. | Chief Executive Officer | - |
TEI Biosciences, Inc.
 TEI Biosciences, Inc. BiotechnologyHealth Technology TEI Biosciences, Inc. develops and distributes novel biologic products for soft tissue repair, reinforcement and reconstruction applications. Its products include SurgiMend 1.0-4.0, SurgiMend-e, SurgiMend PRS, PriMatrix, PriMatrix AG, Durepair, TissueMend and Xenform. The firm’s products are used in general surgery, plastic and reconstructive surgery, trauma, wound care and burns, neurosurgery, orthopedics and urogynecology. The company was founded in 1993 and is headquartered in Waltham, MA. | President | - |
Immunotherapy Corp.
 Immunotherapy Corp. Pharmaceuticals: OtherHealth Technology Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million. | President | - |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | President | - |
Training of David Dove
| New York University | Doctorate Degree |
| University of California, Berkeley | Masters Business Admin |
| Middlebury College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Shire Regenerative Medicine, Inc.
Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Health Technology |
TEI Biosciences, Inc.
TEI Biosciences, Inc. BiotechnologyHealth Technology TEI Biosciences, Inc. develops and distributes novel biologic products for soft tissue repair, reinforcement and reconstruction applications. Its products include SurgiMend 1.0-4.0, SurgiMend-e, SurgiMend PRS, PriMatrix, PriMatrix AG, Durepair, TissueMend and Xenform. The firm’s products are used in general surgery, plastic and reconstructive surgery, trauma, wound care and burns, neurosurgery, orthopedics and urogynecology. The company was founded in 1993 and is headquartered in Waltham, MA. | Health Technology |
Immunotherapy Corp.
Immunotherapy Corp. Pharmaceuticals: OtherHealth Technology Part of Sarepta Therapeutics, Inc., Immunotherapy Corp. develops cancer treatments. The company is based in Seattle, WA. The CEO of the company is Amnon Gonenne. Immunotherapy was acquired by AntiVirals, Inc. on November 06, 1997 for $24 million. | Health Technology |
Aeris Therapeutics LLC
Aeris Therapeutics LLC Medical SpecialtiesHealth Technology Aeris Therapeutics LLC develops therapies for patients with emphysema and other lung diseases. Its product AeriSeal System is designed to reduce lung volume in order to improve lung function and quality of life in patients with advanced emphysema. The company was founded in 2001 and it is headquartered in Woburn, MA. | Health Technology |
Intera Oncology, Inc.
Intera Oncology, Inc. Medical DistributorsDistribution Services Intera Oncology, Inc. provides healthcare services. The company is headquartered in Wellesley, MA. | Distribution Services |
Atacama Therapeutics, Inc.
Atacama Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Atacama Therapeutics, Inc. is a company that focuses on developing treatments for acne vulgaris. The company is based in Wellesley, MA. The company has a pipeline product called AT-5214. The company was founded by Jefferson E. Davis, Jonathan Reis, Joseph Baron. Joseph Baron has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- David Dove
